Skip to content

BENITEC BIOPHARMA LTD/ADR

CIK 0001552795

← back to feed
Revenue (TTM)
16.16M
+4,174.9% YoY FY Jun 2019
Net Income (TTM)
4.09M
+135.2% YoY FY Jun 2019
EPS Diluted (TTM)
0.02
+128.8% YoY FY Jun 2019
Gross Margin
—
FY Jun 2019
Operating Margin
—
FY Jun 2019
Net Margin
25.3%
FY Jun 2019
Free Cash Flow (TTM)
—
FY Jun 2019
Cash
22.41M
FY Jun 2019
Total Debt
—
FY Jun 2019
Shares Outstanding
257.03M sh
FY Jun 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings